CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.91 -0.20 (-3.82%)
As of: Sep 29, 2026 · 10:17 AM EDT

CNS Pharmaceuticals (CNSP) Receivables - Net (2022 - 2023)

Updated

CNS Pharmaceuticals' Receivables - Net came in at $197,605 for Q4 2023, compared with $1,302 a year earlier and unchanged from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Receivables - Net (2022 - 2023) Analysis & Trends

Going back to Q4 2022, CNS Pharmaceuticals' Receivables - Net data covers 4 quarters.

  • Going back by year, Receivables - Net was $1,302 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 CNS Pharmaceuticals 2.30 Mn -39.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 197,605.00
Sep 30, 2023 197,605.00
Jun 30, 2023 197,605.00
Dec 31, 2022 1,302.00
API Access

CNS Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=CNSP&period=max&api_key=YOUR_API_KEY